The Supreme Court heard oral arguments in Food and Drug Administration v. Alliance for Hippocratic Medicine on March 26, 2024.
The case has challenged the FDA’s 2016 and 2021 actions that removed patient health safeguards for chemical abortion drugs. The Supreme Court is now determining whether Alliance for Hippocratic Medicine has standing to challenge the FDA’s actions, and whether those actions were unlawful.
The Court will spend the next several months deciding important issues about standing, administrative law, conscience rights, and health safeguards for chemical abortion drugs.
Read Litigation Counsel Carolyn McDonnell’s comprehensive analysis of the Supreme Court’s oral arguments in Food and Drug Administration v. Alliance for Hippocratic Medicine.
Debrief-of-Oral-Argument-in-FDA-v.-AHM
